The Weekly Litigation News Digest is now live. Subscribe now

Novel Pharmaceutical Composition - EP3090730

The patent EP3090730 was granted to Novartis on Jul 3, 2024. The application was originally filed on Aug 1, 2007 under application number EP15199469A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3090730

NOVARTIS
Application Number
EP15199469A
Filing Date
Aug 1, 2007
Status
Granted And Under Opposition
Mar 8, 2024
Publication Date
Jul 3, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (8)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ELKINGTON AND FIFEJan 10, 2025ELKINGTON AND FIFEADMISSIBLE
HAMM & WITTKOPPJan 10, 2025-ADMISSIBLE
HAMM & WITTKOPPJan 10, 2025HAMM & WITTKOPPADMISSIBLE
KILBURN & STRODEJan 10, 2025KILBURN & STRODEADMISSIBLE
MAIWALDJan 10, 2025MAIWALDADMISSIBLE
ZENTIVA KSJan 10, 2025HOFFMANN EITLEADMISSIBLE
GALENICUM HEALTH SLUJan 9, 2025GALENICUM HEALTH SLUADMISSIBLE
SCORPIOJan 9, 2025SAGITTARIUSWITHDRAWN

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2004019190
DESCRIPTIONUS2006178518
DESCRIPTIONUS2007105824
DESCRIPTIONUS7160870
DESCRIPTIONWO0189457
DESCRIPTIONWO03098002
DESCRIPTIONWO2004096154
OPPOSITIONUS2001044474
OPPOSITIONUS2006178518
OPPOSITIONWO03098992
OPPOSITIONWO2008136843
OTHEREP1330249
OTHEREP2152237
OTHERWO2008136843
SEARCHUS2001044474
SEARCHUS2006178518

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents